Company Profile
Encompass Health Corporation Stock Price, News & Analysis
- Ticker:
- EHC
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, Encompass Health is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
99.90 USD (+1.24%)
Close
Last updated: June 23, 2026 at 00:00
9.91B USD
Market cap
Why the stock is moving
EHC is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Encompass Health is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Encompass Health is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Encompass Health follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Encompass Health sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Eastside Rehabilitation Hospital now open in Georgia
Source: Encompass Health Corporation
- 02
Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia
Source: Encompass Health Corporation
- 03
Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
Source: Encompass Health Corporation
- 04
Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering
Source: Encompass Health Corporation
- 05
Encompass Health announces private offering of senior notes
Source: Encompass Health Corporation
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Encompass Health Corporation (EHC)?
Encompass Health Corporation (EHC) most recently closed at 99.90 USD, a +1.24% move versus the previous session.
What is the market cap of Encompass Health Corporation (EHC)?
Encompass Health Corporation currently has a market capitalization of 9.91B USD on BioPharmSignal.
What does Encompass Health Corporation do?
Encompass Health is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is EHC stock listed?
Encompass Health Corporation (EHC) is associated with NYSE, Headquartered in the United States and listed on NYSE, Encompass Health is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Encompass?
Encompass Health is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Encompass Health Corporation targeting with Encompass?
Encompass Health is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Health?
Encompass Health is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.